{"id":4724,"date":"2025-12-31T13:58:58","date_gmt":"2025-12-31T13:58:58","guid":{"rendered":"https:\/\/www.lifeviz.com\/publication\/dupilumab-stellt-hautbarrierefunktion-bei-atopischer-dermatitis-wieder-her-ergebnisse-der-phase-4-studie\/"},"modified":"2025-12-31T13:58:58","modified_gmt":"2025-12-31T13:58:58","slug":"dupilumab-stellt-hautbarrierefunktion-bei-atopischer-dermatitis-wieder-her-ergebnisse-der-phase-4-studie","status":"publish","type":"publication","link":"https:\/\/www.lifeviz.com\/de\/publication\/dupilumab-stellt-hautbarrierefunktion-bei-atopischer-dermatitis-wieder-her-ergebnisse-der-phase-4-studie\/","title":{"rendered":"Dupilumab stellt Hautbarrierefunktion bei atopischer Dermatitis wieder her: Ergebnisse der Phase-4-Studie"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","categoriepublication":[],"class_list":["post-4724","publication","type-publication","status-publish","hentry"],"acf":{"type":"","mise_en_avant":false,"lien":"https:\/\/www.jaad.org\/article\/S0190-9622(25)00113-6\/pdf"},"_links":{"self":[{"href":"https:\/\/www.lifeviz.com\/de\/wp-json\/wp\/v2\/publication\/4724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifeviz.com\/de\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/www.lifeviz.com\/de\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/www.lifeviz.com\/de\/wp-json\/wp\/v2\/media?parent=4724"}],"wp:term":[{"taxonomy":"categoriepublication","embeddable":true,"href":"https:\/\/www.lifeviz.com\/de\/wp-json\/wp\/v2\/categoriepublication?post=4724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}